fluorodeoxyglucose f18 has been researched along with Epiphora in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichihara, S; Kubota, T; Moritani, S | 1 |
| Basturk, A; Kilicarslan, A; Ozdemir, E; Turkolmez, S; Yildirim-Poyraz, N | 1 |
| Davis, G; Hardy, TG; Kurniawan, ED; McKelvie, P | 1 |
| Dolak, W; Karanikas, G; Kiesewetter, B; Kletter, K; Lukas, J; Mayerhoefer, ME; Müllauer, L; Pones, M; Raderer, M; Rausch, I; Simonitsch-Klupp, I; Weber, M | 1 |
| Allen, C; Grimes, D; Sullivan, TJ; Valenzuela, AA; Wong, D | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Epiphora
| Article | Year |
|---|---|
Clinicopathologic and immunohistochemical features of primary ductal adenocarcinoma of lacrimal gland: five new cases and review of literature.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Ductal; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lacrimal Apparatus Diseases; Male; Middle Aged; Orbit Evisceration; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Receptors, Androgen; Tomography, X-Ray Computed | 2013 |
4 other study(ies) available for fluorodeoxyglucose f18 and Epiphora
| Article | Year |
|---|---|
PET/CT findings in a case with FDG-avid disseminated lacrimal gland MALToma with sequential development of large B-cell lymphoma and gastric MALToma.
Topics: Aged; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lacrimal Apparatus Diseases; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
Malignant transformation of a lacrimal gland pleomorphic adenoma with pulmonary metastases.
Topics: Adenoma, Pleomorphic; Aged; Carcinoma, Adenoid Cystic; Cell Transformation, Neoplastic; Eye Neoplasms; Fluorodeoxyglucose F18; Humans; Lacrimal Apparatus Diseases; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Diffusion Magnetic Resonance Imaging; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Immunotherapy; Lacrimal Apparatus Diseases; Lung Neoplasms; Lymph Nodes; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Multidetector Computed Tomography; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Remission Induction; Rituximab; Soft Tissue Neoplasms; Splenic Neoplasms; Stomach Neoplasms; Treatment Outcome | 2016 |
Positron emission tomography in the detection and staging of ocular adnexal lymphoproliferative disease.
Topics: Adult; Aged; Conjunctival Neoplasms; Eye Neoplasms; Eyelid Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lacrimal Apparatus Diseases; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Orbital Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |